Ads
related to: ddavp medication for von willebrand's 2 6 4 16 graphed- Prophylaxis Information
Find prophylactic information
for this treatment option.
- Treatment Administration
Learn about treatment storage,
reconstitution, and administration.
- HCP Resources
Resources are available for
healthcare providers.
- Stay Up-to-Date
Stay connected with the latest
updates about VONVENDI®.
- Prophylaxis Information
Search results
Results from the WOW.Com Content Network
Vonicog alfa, sold under the brand names Vonvendi and Veyvondi, is a medication used to control bleeding in adults with von Willebrand disease (an inherited bleeding disorder). [6] [5] [7] [8] It is a recombinant von Willebrand factor. [6] [5] The most common adverse reactions are generalized itching, vomiting, nausea, dizziness, and vertigo. [6]
Desmopressin, sold under the trade name DDAVP among others, is a medication used to treat diabetes insipidus, bedwetting, hemophilia A, von Willebrand disease, and high blood urea levels. [1] In hemophilia A and von Willebrand disease, it should only be used for mild to moderate cases. [ 1 ]
Type 1 von Willebrand Disease in dogs. Type 1 von Willebrand Disease is the most common type, and also the mildest. It occurs when dogs have a mild deficiency in all the proteins making up their ...
In addition, desmopressin (DDAVP) is known to be effective in people with von Willebrand's disease, [17] [18] including people with valvular heart disease. [19] [20] Desmopressin stimulates release of von Willebrand factor from blood vessel endothelial cells by acting on the V2 receptor, which leads to decreased breakdown of Factor VIII.
Von Willebrand disease (VWD) is the most common hereditary blood-clotting disorder in humans. An acquired form can sometimes result from other medical conditions. [1] It arises from a deficiency in the quality or quantity of von Willebrand factor (VWF), a multimeric protein that is required for platelet adhesion. It is known to affect several ...
The most prominent vasopressin analogues include desmopressin (dDAVP), terlipressin, and selepressin, each with distinct pharmacological profiles and clinical uses. Desmopressin, a V2 receptor agonist, is primarily used for treating diabetes insipidus and certain bleeding disorders. [ 3 ]
Vasopressin receptor 2 (V2R), or arginine vasopressin receptor 2 (officially called AVPR2), is a protein that acts as receptor for vasopressin. [5] AVPR2 belongs to the subfamily of G-protein-coupled receptors. Its activity is mediated by the G s type of G proteins, which stimulate adenylate cyclase.
At physiological concentrations 2,6-dimethoxybenzoquinone is an antibacterial substance. [3] At higher concentrations there is evidence that it is mutagenic, [4] [5] cytotoxic, [5] genotoxic, [6] and hepatotoxic. [7] [8] [9] Some reports have challenged its mutagenicity [10] and others exclude such a possibility. [11]
Ads
related to: ddavp medication for von willebrand's 2 6 4 16 graphed